Quest Laboratories
QUESTLAB · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
16.5%
1m
8.7%
3m
7.6%
6m
22.0%
all
17.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 116 0%
97.5
153
Company Overview

Sales
112 Cr
Growth: 42.0%
Profit after Tax
15 Cr
Growth: 6.6%
Micro Cap
191 Cr
P/E: 12.7x
Industry P/E: 31.5x
Fundamentals

Sales (Cr) ₹ 112
Growth 42.0%
EBITDA 16.3%
P/S 1.7x
Dividend 0.0%
P/E 12.7x
Book Value ₹ 10
PEG Ratio 0.3x
ROE 91.6%
P/B N/A
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is primarily engaged in the manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. The company also produces variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC).
Belongs to (1 Indices)